These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 28982366

  • 21. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor.
    Warnecke-Eberz U, Chon SH, Hölscher AH, Drebber U, Bollschweiler E.
    Tumour Biol; 2015 Jun; 36(6):4643-53. PubMed ID: 25631748
    [Abstract] [Full Text] [Related]

  • 22. Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing.
    Song C, Chen H, Wang T, Zhang W, Ru G, Lang J.
    Prostate; 2015 Apr 01; 75(5):500-16. PubMed ID: 25597612
    [Abstract] [Full Text] [Related]

  • 23. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q, Yu Z, Yuan S, Xie W, Li C, Hu Z, Xiang Y, Wu N, Wu L, Bai L, Li Y.
    Oncotarget; 2017 Feb 21; 8(8):13048-13058. PubMed ID: 28055956
    [Abstract] [Full Text] [Related]

  • 24. Upregulated Expression of Serum Exosomal microRNAs as Diagnostic Biomarkers of Lung Adenocarcinoma.
    Feng M, Zhao J, Wang L, Liu J.
    Ann Clin Lab Sci; 2018 Nov 21; 48(6):712-718. PubMed ID: 30610040
    [Abstract] [Full Text] [Related]

  • 25. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L, Qi H, Teng J, Su B, Chen H, Wang C, Xia Q.
    Tumour Biol; 2016 Jun 21; 37(6):7777-84. PubMed ID: 26695145
    [Abstract] [Full Text] [Related]

  • 26. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.
    Baumgart S, Meschkat P, Edelmann P, Heinzelmann J, Pryalukhin A, Bohle R, Heinzelbecker J, Stöckle M, Junker K.
    J Cancer Res Clin Oncol; 2019 Nov 21; 145(11):2725-2736. PubMed ID: 31552489
    [Abstract] [Full Text] [Related]

  • 27. Using Next-generation Sequencing to Identify Novel Exosomal miRNAs as Biomarkers for Significant Hepatic Fibrosis.
    Wang Q, Hu Q, Ying Y, Lu C, Li W, Huang C, Xu W, Li Q, Qi X, Zhang X, Liu X, Du Z, Feng Y, Zhang Y, Li X, Ji Y, Zhang J, Wang J, Chen L, Huang Y.
    Discov Med; 2021 Nov 21; 31(164):147-159. PubMed ID: 35188889
    [Abstract] [Full Text] [Related]

  • 28. Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer.
    Tsuchiyama K, Ito H, Taga M, Naganuma S, Oshinoya Y, Nagano K, Yokoyama O, Itoh H.
    Prostate; 2013 Jun 21; 73(8):827-34. PubMed ID: 23184537
    [Abstract] [Full Text] [Related]

  • 29. Expression of miRNAs derived from plasma exosomes in patients with intestinal Behçet's syndrome.
    Hou CC, Bao HF, Shen Y, Ye JF, Ma HF, Guan JL.
    Clin Exp Rheumatol; 2022 Sep 21; 40(8):1480-1490. PubMed ID: 34665700
    [Abstract] [Full Text] [Related]

  • 30. Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine.
    Fredsøe J, Rasmussen AKI, Thomsen AR, Mouritzen P, Høyer S, Borre M, Ørntoft TF, Sørensen KD.
    Eur Urol Focus; 2018 Dec 21; 4(6):825-833. PubMed ID: 28753866
    [Abstract] [Full Text] [Related]

  • 31. Comparative Study of Extracellular Vesicles from the Urine of Healthy Individuals and Prostate Cancer Patients.
    Bryzgunova OE, Zaripov MM, Skvortsova TE, Lekchnov EA, Grigor'eva AE, Zaporozhchenko IA, Morozkin ES, Ryabchikova EI, Yurchenko YB, Voitsitskiy VE, Laktionov PP.
    PLoS One; 2016 Dec 21; 11(6):e0157566. PubMed ID: 27305142
    [Abstract] [Full Text] [Related]

  • 32. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
    Wang N, Wang L, Yang Y, Gong L, Xiao B, Liu X.
    Biochem Biophys Res Commun; 2017 Nov 25; 493(3):1322-1328. PubMed ID: 28986250
    [Abstract] [Full Text] [Related]

  • 33. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
    Delić D, Eisele C, Schmid R, Baum P, Wiech F, Gerl M, Zimdahl H, Pullen SS, Urquhart R.
    PLoS One; 2016 Nov 25; 11(3):e0150154. PubMed ID: 26930277
    [Abstract] [Full Text] [Related]

  • 34. Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy.
    Duan ZY, Cai GY, Bu R, Lu Y, Hou K, Chen XM.
    Sci Rep; 2016 Mar 22; 6():23498. PubMed ID: 27000966
    [Abstract] [Full Text] [Related]

  • 35. Non‑invasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesicles.
    Koppers-Lalic D, Hackenberg M, de Menezes R, Misovic B, Wachalska M, Geldof A, Zini N, de Reijke T, Wurdinger T, Vis A, van Moorselaar J, Pegtel M, Bijnsdorp I.
    Oncotarget; 2016 Apr 19; 7(16):22566-78. PubMed ID: 26992225
    [Abstract] [Full Text] [Related]

  • 36. miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.
    Corcoran C, Rani S, O'Driscoll L.
    Prostate; 2014 Sep 19; 74(13):1320-34. PubMed ID: 25053345
    [Abstract] [Full Text] [Related]

  • 37. Identification of cell-free microRNAs in the urine of patients with prostate cancer.
    Korzeniewski N, Tosev G, Pahernik S, Hadaschik B, Hohenfellner M, Duensing S.
    Urol Oncol; 2015 Jan 19; 33(1):16.e17-16.e22. PubMed ID: 25445383
    [Abstract] [Full Text] [Related]

  • 38. Detection of exosome miRNAs using molecular beacons for diagnosing prostate cancer.
    Lee J, Kwon MH, Kim JA, Rhee WJ.
    Artif Cells Nanomed Biotechnol; 2018 Jan 19; 46(sup3):S52-S63. PubMed ID: 30033809
    [Abstract] [Full Text] [Related]

  • 39. Urinary-exosomal miR-2909: A novel pathognomonic trait of prostate cancer severity.
    Wani S, Kaul D, Mavuduru RS, Kakkar N, Bhatia A.
    J Biotechnol; 2017 Oct 10; 259():135-139. PubMed ID: 28764970
    [Abstract] [Full Text] [Related]

  • 40. Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue.
    Stephan C, Jung M, Rabenhorst S, Kilic E, Jung K.
    Clin Chem Lab Med; 2015 Jun 10; 53(7):1109-18. PubMed ID: 25720086
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.